$AVNR Recent News U.S. stock futures cut rise after

New Post Public Reply Private Reply Replies (0) Message Board

Jun 21, 2014 at 10:56 AM

$AVNR Recent News

U.S. stock futures cut rise after retail sales 8:53 a.m. Aug. 13, 2013 - Barbara Kollmeyer
Cree, Flowers Foods in focus Tuesday 8:42 a.m. Aug. 13, 2013 - Wallace Witkowski
Yum Brands shares drop on sour China sales 5:23 p.m. Aug. 12, 2013 - Wallace Witkowski
Avanir to promote Merck's diabetes drug Januvia 4:48 p.m. Aug. 12, 2013 - MarketWatch.com
Avanir shares rise after hours on license deal 6:29 p.m. July 2, 2013 - Wallace Witkowski
Avanir, OptiNose enter N. America licensing deal 5:27 p.m. July 2, 2013 - MarketWatch.com
7 gut checks before the stock market's opening bell 6:43 a.m. April 29, 2013 - Shawn Langlois
Avanir Pharmaceuticals shares down 3% 10:37 a.m. Nov. 17, 2010 - Nick Godt
Monday’s biggest gaining and declining stocks 5:25 p.m. Nov. 1, 2010 - Laura Mandaro
Avanir and Allergan lead drug stocks 1:55 p.m. Nov. 1, 2010 - Val Brickates Kennedy
Avanir leads drug stocks north 10:06 a.m. Nov. 1, 2010 - Val Brickates Kennedy
Rexahn, Avanir gain; Sequenom falls 1:32 p.m. April 7, 2010 - Val Brickates Kennedy
Avanir, Opexa gain ahead of presentations 3:16 p.m. April 6, 2010 - Val Brickates Kennedy
Avanir shares jump 10% in pre-market action 9:27 a.m. April 6, 2010 - Val Brickates Kennedy
Drug stocks pressured by J&J report; Avanir jumps 1:49 p.m. Oct. 13, 2009 - Val Brickates Kennedy
Avanir, Acorda move on MS drug updates 3:51 p.m. Oct. 9, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 6:10 p.m. Aug. 11, 2009 - MarketWatch
Avanir soars and Javelin sinks on drug studies 1:15 p.m. Aug. 11, 2009 - Val Brickates Kennedy
Avanir Pharmaceuticals shares up 85% 9:41 a.m. Aug. 11, 2009 - Nick Godt
Avanir climbs on Phase III Zenvia trial success 7:31 a.m. Aug. 11, 2009 - Steve Goldstein

Avanir Gains - AVP-825 Hits Phase III Primary Endpoint - Analyst Blog 12:10 p.m. June 12, 2014 - Zacks.com
Successful Phase 3 results for Avanir migraine product 1:35 p.m. June 10, 2014 - Seeking Alpha
Ignyta (RXDX) Jumps: Stock Adds 12.7% in Session - Tale of the Tape 8:51 a.m. June 3, 2014 - Zacks.com
Patients Enrolled in Avanir Study - Analyst Blog 5:35 p.m. June 2, 2014 - Zacks.com
Pipeline Update from Avanir - Analyst Blog 5:00 p.m. June 2, 2014 - Zacks.com
NPS Pharmaceuticals (NPSP) in Focus: Stock Rises 13.4% - Tale of the Tape 9:46 a.m. June 2, 2014 - Zacks.com
Biodel Q2 Loss Wider Than Expected - Analyst Blog 10:20 a.m. May 16, 2014 - Zacks.com
Stock To Watch: AVANIR Pharmaceuticals (AVNR) In Perilous Reversal 10:06 a.m. May 15, 2014 - TheStreet.com
Avanir Pharmaceuticals (AVNR) in Focus: Stock Moves 6.1% Higher - Tale of the Tape 9:18 a.m. May 15, 2014 - Zacks.com
Avanir (AVNR) Shares March Higher, Can It Continue? - Tale of the Tape 8:52 a.m. May 15, 2014 - Zacks.com
QLT Inc. (QLTI) Falls: Stock Goes Down 9.13% - Tale of the Tape 9:00 a.m. May 14, 2014 - Zacks.com
Big Swing Trade Ideas for Monday, May 12 10:28 a.m. May 12, 2014 - TheStreet.com
Avanir Loss In Line with Ests, Revs Up - Analyst Blog 5:00 p.m. May 8, 2014 - Zacks.com
10-Q: AVANIR PHARMACEUTICALS, INC. 2:33 p.m. May 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Avanir Pharmaceuticals' (AVNR) CEO Keith Katkin on Q2 2014 Results - Earnings Call Transcript 9:39 p.m. May 6, 2014 - Seeking Alpha
Avanir Pharmaceuticals: Shares Could Have Significant Upside Ahead 1:54 p.m. May 6, 2014 - Seeking Alpha
Notable earnings after Tuesday’s close 5:35 p.m. May 5, 2014 - Seeking Alpha
Avanir prevails in patent case 4:46 p.m. May 5, 2014 - Seeking Alpha
Eight Analyst Stocks to Buy Under $10 for Big Upside 8:27 a.m. May 3, 2014 - 247WallSt.com
Trade-Ideas: AVANIR Pharmaceuticals (AVNR) Is Today's "Dead Cat Bounce" Stock 9:45 a.m. May 2, 2014 - TheStreet.com

Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral Sumatriptan for the Acute Treatment of Migraine 4:00 a.m. June 10, 2014 - PR Newswire - PRF
Health Care Sector Equities Scrutiny -- Research on AVANIR Pharma, Zoetis, Actavis, and Mallinckrodt 7:50 a.m. June 3, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Completion of Patient Enrollment in Study of AVP-923 for the Treatment of Agitation in Patients with Alzheimer's Disease 9:00 a.m. May 27, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Reports Fiscal 2014 Second Quarter Financial and Business Results 4:01 p.m. May 6, 2014 - PR Newswire - PRF
Pre-Market Scans on Top Gainers -- Research on NQ Mobile, AVANIR Pharma, WellPoint, and Aspen Technology 8:50 a.m. May 1, 2014 - PR Newswire - PRF
Fed Shows Confidence in Market with Cut in Bond Buying Stimulus 7:31 a.m. May 1, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Prevails in NUEDEXTA Patent Trial Resulting in Exclusivity Through 2026 3:04 p.m. April 30, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Date of Fiscal 2014 Second Quarter Financial Results and Conference Call 9:01 a.m. April 29, 2014 - GlobeNewswire
Avanir Pharmaceuticals Announces Multiple Data Presentations Highlighting Its Central Nervous System (CNS) Therapeutics Franchise at the 66th Annual Meeting of the American Academy of Neurology 8:30 a.m. April 28, 2014 - PR Newswire - PRF
Pharma Stocks on our Radar -- Research on AVANIR Pharma, Zoetis, Salix Pharma, and Jazz Pharma 12:31 p.m. April 10, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Acceptance of New Drug Application for AVP-825 for the Acute Treatment of Migraine 9:00 a.m. March 26, 2014 - PR Newswire - PRF
Pharmaceutical Equities under Review -- Research on Zoetis, Mylan, AVANIR Pharma and Actavis 11:11 a.m. March 21, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Publication of Research Showing Dextromethorphan has Antidepressant-like Effects In Vivo 9:00 a.m. March 20, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Appointment of Mark Corrigan to Board of Directors 4:00 p.m. March 19, 2014 - PR Newswire - PRF
Galena Biopharma Inc. Share Value Tumbles on News of SEC Investigation 11:26 a.m. March 19, 2014 - ACCESSWIRE
Avanir Pharmaceuticals Presents Data from a Benchmark Study of PBA Symptoms in Veterans with Mild Traumatic Brain Injury 9:40 a.m. March 19, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Presents Data from a Benchmark Study of PBA Symptoms in Veterans with Mild Traumatic Brain Injury 9:00 a.m. March 19, 2014 - PR Newswire - PRF
MannKind Corp.'s Share Value Increases 74% on News of FDA's Preliminary Approval 10:43 a.m. March 3, 2014 - ACCESSWIRE
Avanir Pharmaceuticals to Participate in Two Conferences in March 10:00 a.m. Feb. 28, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 5:00 p.m. Feb. 7, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cars.com Inducement Awards: New CPO Earns Stock Boost

Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...

Wuliangye Aims for Global Branding Boost at Panda Event

Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...

Innovent's SINTBILO® Hits Primary Endpoint in Study

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Strathcona Resources Q3 2026: Dividends, Deals, and Growth

Digging into Strathcona's Third Quarter Strathcona Resources (TSX: SCR) is strutting its stuff again, dropping a third-quarter report that reads like a playbook for solid energy sector performance. First off, let’s talk about that dividend bump. The company decided to sprinkle some cheer with a 7% increase in its quarterly dividend, now at $0.32 per share. Not exactly...

Trimble & Outbuild Integration Boosts Construction Efficiency

Construction Project Management Just Got A Facelift Innovation isn't just for tech geeks fiddling with apps and gadgets; it's seeped into the gritty world of construction, thanks to Trimble and Outbuild. This new integration is like a fresh coat of paint on a rusted fence, boosting efficiency by connecting project documentation directly to live construction schedules. The...

LG's ASIL D Certification: A Game Changer in Autos

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Photocure Navigates AssureMDx's Medicare Journey

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

MWC26 Doha: Bridging Standards for MENA's Future

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Inside Kristallnacht: An XR Journey for a New World

Bridging the Past with Powerful Tech: A Journey to Kristallnacht Let's cut to the chase: if there's a time in history that we all need to sear into our collective consciousness, it's Kristallnacht. Forget the mere notion of reading it from a textbook; now you can dive headfirst into the harrowing events of November 9, 1938, thanks to the cutting-edge initiative inside...

Nutex Health Scores Top Workplace Honor in 2026

Nutex Health: Accolades and Aspirations Nutex Health just snagged something pretty noteworthy: They've been crowned a 2026 Houston Top Workplace by the Houston Chronicle. Now, before you start throwing confetti, let's chew on what this really means. It's no small potatoes, folks. We're talking employee respect and satisfaction measured by Energage’s surveys. It's proof...